Cargando…
Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning
INTRODUCTION: Organ-at-risk segmentation for head and neck cancer radiation therapy is a complex and time-consuming process (requiring up to 42 individual structure, and may delay start of treatment or even limit access to function-preserving care. Feasibility of using a deep learning (DL) based aut...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115982/ https://www.ncbi.nlm.nih.gov/pubmed/37091160 http://dx.doi.org/10.3389/fonc.2023.1137803 |
_version_ | 1785028324216537088 |
---|---|
author | Lucido, J. John DeWees, Todd A. Leavitt, Todd R. Anand, Aman Beltran, Chris J. Brooke, Mark D. Buroker, Justine R. Foote, Robert L. Foss, Olivia R. Gleason, Angela M. Hodge, Teresa L. Hughes, Cían O. Hunzeker, Ashley E. Laack, Nadia N. Lenz, Tamra K. Livne, Michelle Morigami, Megumi Moseley, Douglas J. Undahl, Lisa M. Patel, Yojan Tryggestad, Erik J. Walker, Megan Z. Zverovitch, Alexei Patel, Samir H. |
author_facet | Lucido, J. John DeWees, Todd A. Leavitt, Todd R. Anand, Aman Beltran, Chris J. Brooke, Mark D. Buroker, Justine R. Foote, Robert L. Foss, Olivia R. Gleason, Angela M. Hodge, Teresa L. Hughes, Cían O. Hunzeker, Ashley E. Laack, Nadia N. Lenz, Tamra K. Livne, Michelle Morigami, Megumi Moseley, Douglas J. Undahl, Lisa M. Patel, Yojan Tryggestad, Erik J. Walker, Megan Z. Zverovitch, Alexei Patel, Samir H. |
author_sort | Lucido, J. John |
collection | PubMed |
description | INTRODUCTION: Organ-at-risk segmentation for head and neck cancer radiation therapy is a complex and time-consuming process (requiring up to 42 individual structure, and may delay start of treatment or even limit access to function-preserving care. Feasibility of using a deep learning (DL) based autosegmentation model to reduce contouring time without compromising contour accuracy is assessed through a blinded randomized trial of radiation oncologists (ROs) using retrospective, de-identified patient data. METHODS: Two head and neck expert ROs used dedicated time to create gold standard (GS) contours on computed tomography (CT) images. 445 CTs were used to train a custom 3D U-Net DL model covering 42 organs-at-risk, with an additional 20 CTs were held out for the randomized trial. For each held-out patient dataset, one of the eight participant ROs was randomly allocated to review and revise the contours produced by the DL model, while another reviewed contours produced by a medical dosimetry assistant (MDA), both blinded to their origin. Time required for MDAs and ROs to contour was recorded, and the unrevised DL contours, as well as the RO-revised contours by the MDAs and DL model were compared to the GS for that patient. RESULTS: Mean time for initial MDA contouring was 2.3 hours (range 1.6-3.8 hours) and RO-revision took 1.1 hours (range, 0.4-4.4 hours), compared to 0.7 hours (range 0.1-2.0 hours) for the RO-revisions to DL contours. Total time reduced by 76% (95%-Confidence Interval: 65%-88%) and RO-revision time reduced by 35% (95%-CI,-39%-91%). All geometric and dosimetric metrics computed, agreement with GS was equivalent or significantly greater (p<0.05) for RO-revised DL contours compared to the RO-revised MDA contours, including volumetric Dice similarity coefficient (VDSC), surface DSC, added path length, and the 95%-Hausdorff distance. 32 OARs (76%) had mean VDSC greater than 0.8 for the RO-revised DL contours, compared to 20 (48%) for RO-revised MDA contours, and 34 (81%) for the unrevised DL OARs. CONCLUSION: DL autosegmentation demonstrated significant time-savings for organ-at-risk contouring while improving agreement with the institutional GS, indicating comparable accuracy of DL model. Integration into the clinical practice with a prospective evaluation is currently underway. |
format | Online Article Text |
id | pubmed-10115982 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101159822023-04-21 Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning Lucido, J. John DeWees, Todd A. Leavitt, Todd R. Anand, Aman Beltran, Chris J. Brooke, Mark D. Buroker, Justine R. Foote, Robert L. Foss, Olivia R. Gleason, Angela M. Hodge, Teresa L. Hughes, Cían O. Hunzeker, Ashley E. Laack, Nadia N. Lenz, Tamra K. Livne, Michelle Morigami, Megumi Moseley, Douglas J. Undahl, Lisa M. Patel, Yojan Tryggestad, Erik J. Walker, Megan Z. Zverovitch, Alexei Patel, Samir H. Front Oncol Oncology INTRODUCTION: Organ-at-risk segmentation for head and neck cancer radiation therapy is a complex and time-consuming process (requiring up to 42 individual structure, and may delay start of treatment or even limit access to function-preserving care. Feasibility of using a deep learning (DL) based autosegmentation model to reduce contouring time without compromising contour accuracy is assessed through a blinded randomized trial of radiation oncologists (ROs) using retrospective, de-identified patient data. METHODS: Two head and neck expert ROs used dedicated time to create gold standard (GS) contours on computed tomography (CT) images. 445 CTs were used to train a custom 3D U-Net DL model covering 42 organs-at-risk, with an additional 20 CTs were held out for the randomized trial. For each held-out patient dataset, one of the eight participant ROs was randomly allocated to review and revise the contours produced by the DL model, while another reviewed contours produced by a medical dosimetry assistant (MDA), both blinded to their origin. Time required for MDAs and ROs to contour was recorded, and the unrevised DL contours, as well as the RO-revised contours by the MDAs and DL model were compared to the GS for that patient. RESULTS: Mean time for initial MDA contouring was 2.3 hours (range 1.6-3.8 hours) and RO-revision took 1.1 hours (range, 0.4-4.4 hours), compared to 0.7 hours (range 0.1-2.0 hours) for the RO-revisions to DL contours. Total time reduced by 76% (95%-Confidence Interval: 65%-88%) and RO-revision time reduced by 35% (95%-CI,-39%-91%). All geometric and dosimetric metrics computed, agreement with GS was equivalent or significantly greater (p<0.05) for RO-revised DL contours compared to the RO-revised MDA contours, including volumetric Dice similarity coefficient (VDSC), surface DSC, added path length, and the 95%-Hausdorff distance. 32 OARs (76%) had mean VDSC greater than 0.8 for the RO-revised DL contours, compared to 20 (48%) for RO-revised MDA contours, and 34 (81%) for the unrevised DL OARs. CONCLUSION: DL autosegmentation demonstrated significant time-savings for organ-at-risk contouring while improving agreement with the institutional GS, indicating comparable accuracy of DL model. Integration into the clinical practice with a prospective evaluation is currently underway. Frontiers Media S.A. 2023-04-06 /pmc/articles/PMC10115982/ /pubmed/37091160 http://dx.doi.org/10.3389/fonc.2023.1137803 Text en Copyright © 2023 Lucido, DeWees, Leavitt, Anand, Beltran, Brooke, Buroker, Foote, Foss, Gleason, Hodge, Hughes, Hunzeker, Laack, Lenz, Livne, Morigami, Moseley, Undahl, Patel, Tryggestad, Walker, Zverovitch and Patel https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Lucido, J. John DeWees, Todd A. Leavitt, Todd R. Anand, Aman Beltran, Chris J. Brooke, Mark D. Buroker, Justine R. Foote, Robert L. Foss, Olivia R. Gleason, Angela M. Hodge, Teresa L. Hughes, Cían O. Hunzeker, Ashley E. Laack, Nadia N. Lenz, Tamra K. Livne, Michelle Morigami, Megumi Moseley, Douglas J. Undahl, Lisa M. Patel, Yojan Tryggestad, Erik J. Walker, Megan Z. Zverovitch, Alexei Patel, Samir H. Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning |
title | Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning |
title_full | Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning |
title_fullStr | Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning |
title_full_unstemmed | Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning |
title_short | Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning |
title_sort | validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planning |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115982/ https://www.ncbi.nlm.nih.gov/pubmed/37091160 http://dx.doi.org/10.3389/fonc.2023.1137803 |
work_keys_str_mv | AT lucidojjohn validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT deweestodda validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT leavitttoddr validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT anandaman validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT beltranchrisj validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT brookemarkd validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT burokerjustiner validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT footerobertl validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT fossoliviar validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT gleasonangelam validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT hodgeteresal validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT hughesciano validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT hunzekerashleye validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT laacknadian validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT lenztamrak validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT livnemichelle validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT morigamimegumi validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT moseleydouglasj validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT undahllisam validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT patelyojan validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT tryggestaderikj validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT walkermeganz validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT zverovitchalexei validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning AT patelsamirh validationofclinicalacceptabilityofdeeplearningbasedautomatedsegmentationoforgansatriskforheadandneckradiotherapytreatmentplanning |